Clinical Trial Update: Efficacy and Safety of Dapagliflozin in Patients with Non-alcoholic Steatohepatitis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the efficacy and safety of dapagliflozin in patients with non-alcoholic steatohepatitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-alcoholic Steatohepatitis

Drugs mentioned

• Dapagliflozin (dapagliflozin)

Snippet

Sponsor: Cairo University | Conditions: Non-alcoholic Steatohepatitis | Phase 2 | Status: COMPLETED